Synapse - Christian Grommes

Search Within

Christian Grommes

Results (154)

SARS‐CoV‐2 infection in 50 patients with primary CNS lymphoma: Presentation, effects on tumor treatment and outcome in a series of the International PCNSL Collaborative Group

Meeting Abstract

Ferreri, A. J. M.; Steffanoni, S.; Calimeri, T.; Laurenge, A.; Fox, C. P.; Soussain, C.; Grommes, C.; Sassone, M. C.; Touat, M.; Boot, J.; more...
Hematological Oncology (2021)

Fulltext@MSK | Save

Clinical trial of proton craniospinal irradiation for leptomeningeal metastases

Journal Article

Yang, T. J.; Wijetunga, N. A.; Yamada, J.; Wolden, S.; Mehallow, M.; Goldman, D. A.; Zhang, Z.; Young, R. J.; Kris, M. G.; Yu, H. A.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Phase Ib trial with dose expansion of the Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, in combination with rituximab and lenalidomide in patients with refractory/recurrent primary central nervous system lymphoma (PCNSL) and refractory/recurrent secondary central nervous system lymphoma (SCNSL)

Meeting Abstract

Grommes, C.; Piotrowski, A.; Pentsova, E.; Nolan, C.; Francis, J.; DeAngelis, L.; Schaff, L.; Mellinghoff, I. K.
Blood (2020)

Fulltext@MSK | Save

Pilot study of repeated planned glucarpidase following high dose methotrexate (HD-MTX) in CNS lymphoma (CNSL)

Meeting Abstract

Schaff, L.; Lobbous, M.; Sener, U.; Gavrilovic, I.; Miller, A.; Stone, J.; Piotrowski, A.; Skakodub, A.; Madzsar, J.; Schumpp, A.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Diffusion MR imaging derived apparent diffusion coefficient as a potential biomarker of clinical outcome in recurrent central nervous system lymphoma

Meeting Abstract

Ho, K. W.; Nosov, A.; Young, R.; Grommes, C.
Neuro-Oncology (2020)

Fulltext@MSK | Save

Planned-use glucarpidase for outpatient high dose methotrexate (HD-MTX) administration in patients with CNS lymphoma (CNSL) during the COVID-19 pandemic

Meeting Abstract

Schaff, L.; Lobbous, M.; Bozza, A.; Carlow, D.; Nabors, L.; Grommes, C.
Neuro-Oncology (2020)

Fulltext@MSK | Save

Preliminary results of a phase II study of nivolumab with hypofractionated re-radiation and bevacizumab for recurrent MGMT methylated glioblastoma

Meeting Abstract

Grommes, C.; Mehta, M.; Miller, A.; Daras, M.; Piotrowski, A.; Boire, A.; Butler, B.; Stone, J.; Pentsova, E.; Kotecha, R.; more...
Neuro-Oncology (2020)

Fulltext@MSK | Save

Challenges in the treatment of newly diagnosed and recurrent primary central nervous system lymphoma

Review

Holdhoff, M.; Mrugala, M. M.; Grommes, C.; Kaley, T. J.; Swinnen, L. J.; Perez-Heydrich, C.; Nayak, L.
Journal of the National Comprehensive Cancer Network (2020)

Fulltext@MSK | Save

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (RMPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL)

Meeting Abstract

Omuro, A. M. P.; DeAngelis, L. M.; Karrison, T.; Bovi, J. A.; Rosenblum, M.; Corn, B. W.; Correa, D.; Wefel, J. S.; Aneja, S.; Grommes, C.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Imaging CXCR4 expression with iodinated and brominated cyclam derivatives

Journal Article

Zhang, H.; Maeda, M.; Shindo, M.; Ko, M.; Mane, M.; Grommes, C.; Weber, W.; Blasberg, R.
Molecular Imaging and Biology (2020)

Fulltext@MSK | Save